Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of PersistenceB-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Tumor Virus Infections, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious diseaseRecruitingPhase 1 / Phase 22024-05-29NCT05310591

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Assistance Publique - Hôpitaux de Paris985

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
CHRU BordeauxBordeauxFrance1
CHRU LilleLilleFrance32
CHRU StrasbourgStrasbourgFrance11
CHU Montpellier - Hopital Arnaud de VilleneuveMontpellierFrance1
CHU NancyNancyFrance24
CHU Nantes - Hopital Mère-enfantsNantesFrance1
CHU RouenRouenFrance49
HCLLyonFrance13
HCL - Lyon SudLyonFrance4
Hôpital pour enfants - La TimoneMarseilleFrance1
Robert Debre hospitalParisFrance1
Saint Louis HospitalParisFrance7